default author photo

Dominic Dwyer

The University of Sydney - Westmead Hospital

Hawkesbury Rd & Darcy Road

Westmead NSW 2145

Australia

SCHOLARLY PAPERS

6

DOWNLOADS

794

TOTAL CITATIONS

1

Scholarly Papers (6)

1.

Diagnostic and Phylogenetic Perspectives of the 2023 Murray Valley Encephalitis Virus Outbreak in Australia

Number of pages: 28 Posted: 06 Feb 2024
The University of Sydney - Westmead Hospital, Government of the Commonwealth of Australia - Australian Centre for Disease Preparedness, Royal Darwin Hospital, University of Melbourne - Victorian Infectious Disease Reference Laboratory, The University of Sydney, Government of the Commonwealth of Australia - Australian Centre for Disease Preparedness, Government of the Commonwealth of Australia - Australian Centre for Disease Preparedness, The University of Sydney - Westmead Hospital, Royal Darwin Hospital, The University of Sydney - Westmead Hospital, University of Melbourne - Victorian Infectious Disease Reference Laboratory, Queen Elizabeth II Medical Centre - PathWest Laboratory Medicine WA, Queen Elizabeth II Medical Centre - PathWest Laboratory Medicine WA, The Austin Hospital - Department of Infectious Diseases, Queensland Health - Public and Environmental Health, Forensic and Scientific Services, NT Health - Centre for Disease Control, Public Health Division, Queensland Health - Public and Environmental Health, Forensic and Scientific Services, Queensland Health - Public and Environmental Health, Forensic and Scientific Services, Queensland Health - Public and Environmental Health, Forensic and Scientific Services, Australian Government - Department of Health, AgriBio - Centre for AgriBioscience - Agriculture Victoria, Victorian Department of Health - Communicable Diseases Section, The University of Sydney - Westmead Hospital, The University of Sydney - Sydney Infectious Diseases Institute, The Austin Hospital - Department of Infectious Diseases, SA Pathology, SA Pathology, Queensland Health - Public and Environmental Health, Forensic and Scientific Services, University of Melbourne - Victorian Infectious Disease Reference Laboratory, Royal Darwin Hospital, Queen Elizabeth II Medical Centre - PathWest Laboratory Medicine WA, Government of the Commonwealth of Australia - Australian Centre for Disease Preparedness, Charles Darwin University - Menzies School of Health Research and Westmead Hospital - Centre for Infectious Diseases and Microbiology Laboratory Services, NSW Health Pathology-Institute of Clinical Pathology and Medical Research
Downloads 226 (337,699)

Abstract:

Loading...

Murray Valley encephalitis, Murray Valley encephalitis virus, flavivirus, encephalitis, One Health, climate change, zoonosis, pathogen genomics

2.

Seroprevalence of Japanese Encephalitis Virus and Other Flavivirus-Specific Antibodies Among Blood Donors in Australia Following a Novel Epidemic Spread of Japanese Encephalitis Virus

Number of pages: 40 Posted: 01 Jun 2025
Children’s Hospital at Westmead - The National Centre for Immunisation Research and Surveillance (NCIRS), National Centre for Immunisation Research and Surveillance, National Centre for Immunisation Research and Surveillance, Macquarie University, The University of Sydney, The University of Sydney - Westmead Hospital, The University of Sydney - Sydney Infectious Diseases Institute, National Centre for Immunisation Research and Surveillance, Australian Red Cross, Westmead Hospital - Centre for Infectious Diseases and Microbiology Laboratory Services, NSW Health Pathology-Institute of Clinical Pathology and Medical Research, Australian Red Cross, National Centre for Immunisation Research and Surveillance, National Centre for Immunisation Research and Surveillance, Charles Darwin University - Menzies School of Health Research, The University of Sydney - Westmead Hospital, Australian Red Cross and Children’s Hospital at Westmead - The National Centre for Immunisation Research and Surveillance (NCIRS)
Downloads 175 (433,279)

Abstract:

Loading...

Japanese encephalitis virus, Japanese encephalitis, Murray Valley encephalitis virus, Murray Valley encephalitis, Kunjin virus, West Nile virus, serosurvey, blood donor, zoonosis, arbovirus, epidemiology

3.

A Phase I, Double-Blind, Dose-Ranging, Randomised, Placebo-Controlled Trial to Study the Safety and Immunogenicity of a DNA-Based Vaccine Against COVID-19 (COVIGEN) in Healthy SARS-CoV-2 Vaccine-Naïve Participants Aged 18 to 59 Years Old

Number of pages: 38 Posted: 21 Mar 2024
Children’s Hospital at Westmead - The National Centre for Immunisation Research and Surveillance (NCIRS), Perth Children’s Hospital - Wesfarmer's Centre for Vaccines and Infectious Diseases, The University of Western Australia, Scientia Clinical Research Ltd, University of Adelaide - Vaccinology and Immunology Research Trials Unit, The University of Sydney - Westmead Institute for Medical Research, The University of Sydney - Westmead Institute for Medical Research, The University of Sydney - Westmead Institute for Medical Research, The University of Sydney - NSW Health Pathology, The University of Sydney - Westmead Hospital, The University of Sydney - Sydney Infectious Diseases Institute, The University of Sydney - Westmead Hospital, Perth Children’s Hospital - Wesfarmer's Centre for Vaccines and Infectious Diseases, Technovalia Pty. Ltd., Technovalia Pty. Ltd., BioNet-Asia Co Ltd and The University of Sydney - Westmead Institute for Medical Research
Downloads 115 (617,542)

Abstract:

Loading...

DNA, SARS-CoV-2, vaccine, neutralising antibody, COVID-19, safety, immunogenicity

4.

Long-Term Persistence of Neutralizing Memory B Cells in SARS-CoV-2

Number of pages: 35 Posted: 25 Nov 2020
University of New South Wales (UNSW) - Kirby Institute, University of New South Wales (UNSW) - School of Medical Sciences (SoMS), University of New South Wales (UNSW) - Kirby Institute, University of New South Wales (UNSW) - School of Medical Sciences (SoMS), University of New South Wales (UNSW) - Kirby Institute, University of New South Wales (UNSW) - Kirby Institute, University of New South Wales (UNSW) - Kirby Institute, Garvan Institute of Medical Research, Garvan Institute of Medical Research, Garvan Institute of Medical Research, University of Adelaide - Viral Immunology Group, Government of New South Wales - Virology Research Laboratory, University of New South Wales (UNSW) - Kirby Institute, University of New South Wales (UNSW) - Kirby Institute, The University of Sydney - School of Medical Sciences, Northern Beaches Hospital, University of New South Wales (UNSW) - Prince of Wales Clinical School, Royal North Shore Hospital, The University of Sydney - Westmead Hospital, The University of Sydney - Westmead Hospital, University of New South Wales (UNSW) - Kirby Institute, The University of Sydney - School of Medical Sciences, The University of Sydney - School of Medical Sciences, University of New South Wales (UNSW) - School of Medical Sciences (SoMS), University of New South Wales (UNSW) - Kirby Institute, University of New South Wales (UNSW) - Kirby Institute, University of New South Wales (UNSW) - Kirby Institute and Independent
Downloads 110 (640,165)

Abstract:

Loading...

SARS-CoV-2, neutralising antibodies, RBD, memory B cells

5.

Cross-Sectional and Longitudinal Genotype to Phenotype Surveillance of SARS-CoV-2 Variants Over the First Four Years of the COVID-19 Pandemic

Number of pages: 28 Posted: 04 Jun 2024
University of New South Wales (UNSW) - Kirby Institute, University of New South Wales (UNSW) - Kirby Institute, University of New South Wales (UNSW) - Kirby Institute, University of Newcastle - Hunter Medical Research Institute, University of New South Wales (UNSW) - Kirby Institute, University of New South Wales (UNSW) - Kirby Institute, The University of Sydney - Sydney Institute for Infectious Diseases, Government of New South Wales - Serology and Virology Division (SAViD), Government of New South Wales - Serology and Virology Division (SAViD), CSL Behring AG - Department of Bioanalytical Sciences, CSL Behring AG - Department of Bioanalytical Sciences, CSL Behring AG, CSL Behring AG, CSL Behring AG, CSL Behring AG, Government of New South Wales - Virology Research Laboratory, CSL Behring AG - Department of Bioanalytical Sciences, Karolinska Institutet, University of Newcastle (Australia) - Viral Immunology and Respiratory Disease Group, St. Vincent's Hospital, University of New South Wales (UNSW) - Kirby Institute, St. Vincent's Hospital - Molecular Diagnostic Medicine Laboratory, Histopath Diagnostic Specialists, Government of New South Wales - Virology Research Laboratory, Karolinska Institutet - Department of Microbiology, Tumor and Cell Biology (MTC), University of New South Wales (UNSW) - Kirby Institute, The University of Sydney - Westmead Hospital, Westmead Hospital - Centre for Infectious Diseases and Microbiology - Public Health, Westmead Hospital - Centre for Infectious Diseases and Microbiology Laboratory Services, NSW Health Pathology-Institute of Clinical Pathology and Medical Research, NSW Health, NSW Health, Australian Red Cross, Australian Red Cross, Australian Red Cross, Australian Red Cross, University of New South Wales (UNSW), The University of Sydney - School of Medical Sciences, University of New South Wales (UNSW) - Kirby Institute and University of New South Wales (UNSW) - Kirby Institute
Downloads 104 (674,591)
Citation 1

Abstract:

Loading...

SARS-CoV-2, COVID-19, neutralisation, population immunity

6.

Maintenance of Broad Neutralising Antibodies and Memory B Cells 12 Months Post-Infection Is Predicted by SARS-CoV-2 Specific CD4+ T Cell Responses

Number of pages: 54 Posted: 09 Sep 2021
University of New South Wales (UNSW) - School of Medical Sciences (SoMS), University of New South Wales (UNSW) - Kirby Institute, University of New South Wales (UNSW) - Kirby Institute, University of New South Wales (UNSW) - School of Medical Sciences (SoMS), University of New South Wales (UNSW) - School of Medical Sciences (SoMS), University of New South Wales (UNSW) - Kirby Institute, University of New South Wales (UNSW), University of New South Wales (UNSW) - Kirby Institute, University of New South Wales (UNSW) - School of Medical Sciences (SoMS), University of New South Wales (UNSW) - Kirby Institute, Garvan Institute of Medical Research, Garvan Institute of Medical Research, University of New South Wales (UNSW) - Kirby Institute, University of New South Wales (UNSW) - The Kirby Institute, University of Adelaide - Viral Immunology Group, Government of New South Wales - Virology Research Laboratory, University of New South Wales (UNSW) - Kirby Institute, affiliation not provided to SSRN, University of New South Wales (UNSW) - Kirby Institute, Northern Beaches Hospital, University of New South Wales (UNSW) - Prince of Wales Clinical School, Royal North Shore Hospital, The University of Sydney - Westmead Hospital, St George Hospital, Western Sydney University, The University of Sydney - Westmead Hospital, The University of Sydney, University of New South Wales (UNSW) - Kirby Institute, University of New South Wales (UNSW) - School of Medical Sciences (SoMS), University of New South Wales (UNSW) - Kirby Institute, University of New South Wales (UNSW) - Kirby Institute and University of New South Wales (UNSW) - Kirby Institute
Downloads 64 (924,743)

Abstract:

Loading...

SARS-CoV-2, 12 months after SARS-CoV-2 infection, RBD-specific memory B cells, protection efficacy prediction, SARS-CoV-2 antibodies, SARS-CoV-2 neutralisation, variants of concern, Delta variant